Neural Regeneration Research

Article	Citations
Mechanosensitivity of N-methyl-D-aspartate receptors (NMDAR) is the key through which amyloid beta oligomers activate them	290
Human endogenous retrovirus type-W and multiple sclerosis–related smoldering neuroinflammation	258
SCFD1 in amyotrophic lateral sclerosis: reconciling a genetic association with in vivo functional analysis	171
Porcine decellularized nerve matrix hydrogel attenuates neuroinflammation after peripheral nerve injury by inhibiting the TLR4/MyD88/NF-κB axis	120
Contribution of adult-born neurons to memory consolidation during rapid eye movement sleep	108
LL-37 and CsgC exemplify the crosstalk between anti-amyloid, antimicrobial, and anti-biofilm protein activities	97
Ethanol changes Nestin-promoter induced neural stem cells to disturb newborn dendritic spine remodeling in the hippocampus of mice	88
Functions of nuclear factor Y in nervous system development, function and health	81
The role of miRNA in retinal ganglion cell health and disease	79
Enhancement of lysosome biogenesis as a potential therapeutic approach for neurodegenerative diseases	64
Prolonged intermittent theta burst stimulation restores the balance between A2AR- and A1R-mediated adenosine signaling in the 6-hydroxidopamine model of Parkinson’s disease	62
Transcription factors promote neural regeneration after spinal cord injury	59
Eph receptor A4 regulates motor neuron ferroptosis in spinal cord ischemia/reperfusion injury in rats	58
Axonal protein synthesis in central nervous system regeneration: is building an axon a local matter?	56
Generating oligodendroglia from adult mesenchymal cells for transplantation: cell reprogramming or direct lineage conversion?	52
NECAB family of neuronal calcium-binding proteins in health and disease	50
Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics	50
Bradykinin postconditioning protects rat hippocampal neurons after restoration of spontaneous circulation following cardiac arrest via activation of the AMPK/mTOR signaling pathway	50
Chronic traumatic encephalopathy: genes load the gun and repeated concussion pulls the trigger	49
Protocadherin gamma C3: a new player in regulating vascular barrier function	49
Mesenchymal stem cell-derived extracellular vesicles therapy in traumatic central nervous system diseases: a systematic review and meta-analysis	48
Chx10+V2a interneurons in spinal motor regulation and spinal cord injury	47
Rbm8a regulates neurogenesis and reduces Alzheimer’s disease-associated pathology in the dentate gyrus of 5×FAD mice	47
Exercise-with-melatonin therapy improves sleep disorder and motor dysfunction in a rat model of ischemic stroke	47
Retraction: Emerging concepts underlying selective neuromuscular dysfunction in infantile-onset spinal muscular atrophy	46

Role of copper chelating agents: between old applications and new perspectives in neuroscience	45
Increased activation of the caudate nucleus and parahippocampal gyrus in Parkinson’s disease patients with dysphagia after repetitive transcranial magnetic stimulation: a case-control study	45
Synaptopathy in CHMP2B frontotemporal dementia highlights the synaptic vesicle cycle as a therapeutic target	44
Neuroserpin alleviates cerebral ischemia-reperfusion injury by suppressing ischemia-induced endoplasmic reticulum stress	44
Neuropsychiatric symptoms and apolipoprotein E genotypes in neurocognitive disorders	44
Could inorganic polyphosphate be a valid target against neuronal senescence?	43
Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders	43
Clemastine in remyelination and protection of neurons and skeletal muscle after spinal cord injury	43
Involvement of glucose transporter overexpression in the protection or damage after ischemic stroke	43
Rapid GFAP and Iba1 expression changes in the female rat brain following spinal cord injury	42
Decoding molecular mechanisms: brain aging and Alzheimer’s disease	42
Dual-targeting AAV9P1-mediated neuronal reprogramming in a mouse model of traumatic brain injury	41
Facial reanimation with interposition nerve graft or masseter nerve transfer: a comparative retrospective study	41
Krüppel-like factor 2 (KLF2), a potential target for neuroregeneration	41
Glymphatic imaging and modulation of the optic nerve	40
Neurogenesis dynamics in the olfactory bulb: deciphering circuitry organization, function, and adaptive plasticity	40
The circ_0002538/miR-138-5p/plasmolipin axis regulates Schwann cell migration and myelination in diabetic peripheral neuropathy	39
The power of “touch” and early enriched stimulation: neuroplasticity effects in rodents and preterm infants	39
Increased retinal venule diameter as a prognostic indicator for recurrent cerebrovascular events: a prospective observational study	39
Astrocyte chloride, excitatory-inhibitory balance and epilepsy	39
Phosphorylated tau as a toxic agent in synaptic mitochondria: implications in aging and Alzheimer’s disease	38
Peripheral mitochondrial DNA as a neuroinflammatory biomarker for major depressive disorder	37
The delivery of miR-21a-5p by extracellular vesicles induces microglial polarization via the STAT3 pathway following hypoxia-ischemia in neonatal mice	37
Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety	37
Exosomes derived from bone marrow mesenchymal stem cells protect the injured spinal cord by inhibiting pericyte pyroptosis	37
Tropism-shifted AAV-PHP.eB-mediated bFGF gene therapy promotes varied neurorestoration after ischemic stroke in mice	36
Rapamycin as a preventive intervention for Alzheimer’s disease in APOE4 carriers: Targeting brain metabolic and vascular restoration	36
Neuromodulation techniques for modulating cognitive function: Enhancing stimulation precision and intervention effects	36
Small extracellular vesicles secreted by induced pluripotent stem cell-derived mesenchymal stem cells improve postoperative cognitive dysfunction in mice with diabetes	35
Autolysosomal acidification impairment as a mediator for TNFR1 induced neuronal necroptosis in Alzheimer's disease	35
Mitochondrial transplantation: a promising strategy for the treatment of retinal degenerative diseases	35
Stepping up after spinal cord injury: negotiating an obstacle during walking	35
Necrostatin-1 decreases necroptosis and inflammatory markers after intraventricular hemorrhage in mice	34
Role of the globus pallidus in motor and non-motor symptoms of Parkinson’s disease	34
Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway	34
Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy	34
Functional near-infrared spectroscopy in non-invasive neuromodulation	33
Downregulation of miR-491-5p promotes neovascularization after traumatic brain injury	33
The complex roles of m6A modifications in neural stem cell proliferation, differentiation, and self-renewal and implications for memory and neurodegenerative diseases	33
Activation of medial septum cholinergic neurons restores cognitive function in temporal lobe epilepsy	33
Amyloid-beta and tau protein beyond Alzheimer’s disease	32
GDNF to the rescue: GDNF delivery effects on motor neurons and nerves, and muscle re-innervation after peripheral nerve injuries	32
Selective deletion of zinc transporter 3 in amacrine cells promotes retinal ganglion cell survival and optic nerve regeneration after injury	32
Neurodevelopmental defects as a primer of neurodegeneration: lessons from spinal muscular atrophy and Huntington's disease	31
Commentary on “PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons”	31
Multiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons	31
New aspects of a small GTPase RAB35 in brain development and function	31
Extracellular vesicles: multiple signaling capabilities and translation into promising therapeutic targets to promote neuronal plasticity	31
Blocking postsynaptic density-93 binding to C-X3-C motif chemokine ligand 1 promotes microglial phenotypic transformation during acute ischemic stroke	31
Crosstalk among canonical Wnt and Hippo pathway members in skeletal muscle and at the neuromuscular junction	31

Insights from an academic endeavor into central nervous system drug discovery	30
Neuronal and endothelial transglutaminase-2 expression in experimental autoimmune encephalomyelitis and multiple sclerosis	30
Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease	30
Utility of droplet digital polymerase chain reaction for studying somatic mosaicism: brain malformations and beyond	30
Brain ischemia as a bridge to Alzheimer’s disease	30
Endorepellin downregulation promotes angiogenesis after experimental traumatic brain injury	29
Amyotrophic lateral sclerosis disease burden: doing better at getting better	29
A Drosophila perspective on retina functions and dysfunctions	29
NOVA1 promotes SMN2 exon 7 splicing by binding the UCAC motif and increases SMN protein expression	29
Cell senescence, loss of splicing, and lipid metabolism in TDP-43-related neurodegenerative processes	28
Premature axon-oligodendrocyte interaction contributes to stalling of experimental axon regeneration after injury to the white matter	28
Neuron-fibrous scaffold interfaces in the peripheral nervous system: a perspective on the structural requirements	28
The secondary injury cascade after spinal cord injury: an analysis of local cytokine/chemokine regulation	28
Exploration of C-terminal CX3CL1 for reducing age-dependent neurodegeneration	28
Post-acute ischemic stroke hyperglycemia aggravates destruction of the blood-brain barrier	27
Biochanin A attenuates spinal cord injury in rats during early stages by inhibiting oxidative stress and inflammasome activation	27
New insights into the role of the endoplasmic reticulum in microglia	27
Effects of electroacupuncture on the functionality of NG2-expressing cells in perilesional brain tissue of mice following ischemic stroke	27
Designing nanocarriers to overcome the limitations in conventional drug administration for Parkinson’s disease	27
Argatroban promotes recovery of spinal cord injury by inhibiting the PAR1/JAK2/STAT3 signaling pathway	27
Microglia depletion as a therapeutic strategy: friend or foe in multiple sclerosis models?	26
On the functions of astrocyte-mediated neuronal slow inward currents	26
Prediction of cell-cell communication patterns of dorsal root ganglion cells: single-cell RNA sequencing data analysis	26
Therapeutic effects of low-intensity transcranial focused ultrasound stimulation on ischemic stroke in rats: an in vivo evaluation using electrical impedance tomography	26
Retraction: Ultrasound guided neural stem cell transplantation through the lateral ventricle for treatment of cerebral palsy in children	26
Modulation of p75 neurotrophin receptor mitigates brain damage following ischemic stroke in mice	26
Pharmacological interventions targeting the microcirculation following traumatic spinal cord injury	26
Ki20227 aggravates apoptosis, inflammatory response, and oxidative stress after focal cerebral ischemia injury	26
Advances in non-invasive imaging of proteinopathies in animal models of neurodegenerative diseases	26
microRNA-455-5p alleviates neuroinflammation in cerebral ischemia/reperfusion injury	25
Role of calcium homeostasis in retinal ganglion cell degeneration	25
NLRP3/1-mediated pyroptosis: beneficial clues for the development of novel therapies for Alzheimer’s disease	25
Dynamic regulation of the developmental establishment of the adult hippocampal neural stem cell pool	25
Effects of C2 hemisection on respiratory and cardiovascular functions in rats	25
Erythropoietin inhibits ferroptosis and ameliorates neurological function after spinal cord injury	25
Newfound physiological function of FAIM protein offers hope of novel disease-modifying therapy for Alzheimer’s disease	25
Regulatory role of neuronal guidance proteins in spinal cord injury	25
Ruxolitinib attenuates secondary injury after traumatic spinal cord injury	25
Utilizing engineered extracellular vesicles as delivery vectors in the management of ischemic stroke: a special outlook on mitochondrial delivery	25
A review of the neurotransmitter system associated with cognitive function of the cerebellum in Parkinson’s disease	25
Converging assemblies: a putative building block for brain function and for interfacing with the brain	25
Neuroprotection provided by polyphenols and flavonoids in photoreceptor degenerative diseases	25
Small extracellular vesicles derived from cerebral endothelial cells with elevated microRNA 27a promote ischemic stroke recovery	25
Treatment with β-sitosterol ameliorates the effects of cerebral ischemia/reperfusion injury by suppressing cholesterol overload, endoplasmic reticulum stress, and apoptosis	25
Dysfunction of synaptic endocytic trafficking in Parkinson’s disease	24
Exendin-4 and linagliptin attenuate neuroinflammation in a mouse model of Parkinson′s disease	24
Optical tissue clearing enables rapid, precise and comprehensive assessment of three-dimensional morphology in experimental nerve regeneration research	24
The neuroprotective effects of oxygen therapy in Alzheimer’s disease: a narrative review	24
Functions and mechanisms of cytosolic phospholipase A2 in central nervous system trauma	24
Unraveling the role of ufmylation in the brain	24
Sex modulates the outcome of subthalamic nucleus deep brain stimulation in patients with Parkinson’s disease	24
M2 macrophages mediate fibrotic scar formation in the early stages after cerebral ischemia in rats	24
Targeting muscle to treat Charcot-Marie-Tooth disease	24
Exploring the novel role of oligodendrocyte precursor cells in phagocytosis: beyond myelinogenesis	24
Homer signaling pathways as effective therapeutic targets for ischemic and traumatic brain injuries and retinal lesions	24
A core scientific problem in the treatment of central nervous system diseases: newborn neurons	24
Status of precision medicine approaches to traumatic brain injury	23
New insights on the role of chondroitin sulfate proteoglycans in neural stem cell–mediated repair in spinal cord injury	23
Optogenetics stimulates nerve reorganization in the contralesional anterolateral primary motor cortex in a mouse model of ischemic stroke	23
Role of microtubule dynamics in Wallerian degeneration and nerve regeneration after peripheral nerve injury	23
Making bridges between preclinical and clinical insights into age-related cognitive decline	22
Implication of gut microbiome in age-related macular degeneration	22
Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease	22
Biomaterial-based strategies: a new era in spinal cord injury treatment	22
Secretase inhibition in Alzheimer’s therapeutics reveals functional roles of amyloid-beta42	22
The critical role of the endolysosomal system in cerebral ischemia	22
Post-transcriptional mechanisms controlling neurogenesis and direct neuronal reprogramming	22
Fasudil-modified macrophages reduce inflammation and regulate the immune response in experimental autoimmune encephalomyelitis	22
Neuronal autosis: the self-destructive side of autophagy involved in hypoxic-ischemic neuronal death	22
Semaphorin7A: its role in the control of serotonergic circuits and functional recovery following spinal cord injury	22
Brain-derived cell-free DNA	22
Magnesium-L-threonate treats Alzheimer’s disease by modulating the microbiota-gut-brain axis	22
Delayed activation of leg somatotopic fibers of an injured corticospinal tract in a patient with cerebral infarction	21
Two become one: combination of two risk factors in a new glaucoma animal model	21
Carboplatin restores neuronal toxicity in FUS-linked amyotrophic lateral sclerosis	21
Bioactive material promotes long-distance regeneration of optic nerve to restore visual functions	21
Stiffness-tunable biomaterials provide a good extracellular matrix environment for axon growth and regeneration	21
Schwann cell extracellular vesicles: judging a book by its cover	21
Facial reanimation with interposition nerve graft or masseter nerve transfer: a comparative retrospective study	21
Neuronal chemokines: new insights into neuronal communication after injury	21

Artificial nerve graft constructed by coculture of activated Schwann cells and human hair keratin for repair of peripheral nerve defects	21
Tau’s function and dysfunction in the brain	21
Anti-vascular endothelial growth factor drugs combined with laser photocoagulation maintain retinal ganglion cell integrity in patients with diabetic macular edema: study protocol for a prospective, n	21
Graphene oxide-composited chitosan scaffold contributes to functional recovery of injured spinal cord in rats	21
Application value of biofluid-based biomarkers for the diagnosis and treatment of spinal cord injury	21
Data and subject heterogeneity and data sharing: keys to translational success in spinal cord injury research?	21
Matrin-3 dysfunction in myopathy and motor neuron degeneration	21
Transcranial electrical stimulation in neurological disease	21
Effects of delayed repair of peripheral nerve injury on the spatial distribution of motor endplates in target muscle	21
Differential distribution of PINK1 and Parkin in the primate brain implies distinct roles	20
Effects of quercetin and its derivatives in in vivo models of neuroinflammation: a systematic review and meta-analysis	20
Complement activation kindles the transition of acute post-traumatic brain injury to a chronic inflammatory disease	20
Multiple sclerosis drug repurposing for neuroregeneration	20
Time-to-enrollment in clinical trials investigating neurological recovery in chronic spinal cord injury: observations from a systematic review and ClinicalTrials.gov database	20
Imaging mass spectrometry: a molecular microscope for studying the role of lipids in Parkinson’s disease	20
Profile of the RNA in exosomes from astrocytes and microglia using deep sequencing: implications for neurodegeneration mechanisms	20
Boosting proteolytic pathways as a treatment against glycation-derived damage in the brain?	20
Clues from a missense mutation of the adenosine A1 receptor gene associated with early-onset Parkinson’s disease	20
Mechanosensitive Piezo1 channel regulation of microglial cell function and implications to neurodegenerative diseases and neuroinflammation	20
Adipose mesenchymal stem cell-derived extracellular vesicles reduce glutamate-induced excitotoxicity in the retina	20
Metformin remodels the myelin landscape	20
Current progress of mitochondrial therapy for neural regeneration	20
5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis	20
Knockout of Sirt2 alleviates traumatic brain injury in mice	20
Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?	19
Brain and spinal cord trauma: what we know about the therapeutic potential of insulin growth factor 1 gene therapy	19
Brain-penetrating neurotrophic factor mimetics: HER-096 as a disease-modifying therapy for Parkinson’s disease	19
Sex differences in Alzheimer’s disease: an urgent research venue to follow	19
Neural and Müller glial adaptation of the retina to photoreceptor degeneration	19
Heterogeneity of mature oligodendrocytes in the central nervous system	19
Interconnections between diabetic corneal neuropathy and diabetic retinopathy: diagnostic and therapeutic implications	19
Insights into the transcriptomic heterogeneity of brain endothelial cells in normal aging and Alzheimer’s disease	19
Neuronal plasticity and its role in Alzheimer’s disease and Parkinson’s disease	19
Cerebral dopamine neurotrophic factor transfection in dopamine neurons using neurotensin-polyplex nanoparticles reverses 6-hydroxydopamine-induced nigrostriatal neurodegeneration	19
Unexpected role of complement component 8 gamma chain in the inflamed brain	19
Secretory autophagy in neurons: more than throwing out the trash?	19
The “mitochondrial stress responses”: the “Dr. Jekyll and Mr. Hyde” of neuronal disorders	19
Transcranial photobiomodulation for the brain: a wide range of clinical applications	19
Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer's disease	19
Contribution of glial cells to the neuroprotective effects triggered by repetitive magnetic stimulation	19
Diabetic corneal neuropathy as a surrogate marker for diabetic peripheral neuropathy	19
Blood-brain barrier pathology in cerebral small vessel disease	19
Fibrinogen’s potential role in connecting cerebrovascular abnormalities with glymphatic dysfunction in Alzheimer’s disease	19
Exploring the synergy of the eye-brain connection: neuromodulation approaches for neurodegenerative disorders through transcorneal electrical stimulation	19
Inhibitory gamma-aminobutyric acidergic neurons in the anterior cingulate cortex participate in the comorbidity of pain and emotion	19
Microglial depletion impairs glial scar formation and aggravates inflammation partly by inhibiting STAT3 phosphorylation in astrocytes after spinal cord injury	19
Letter from the Editor-in-Chief	19
Oxidative stress in retinal pigment epithelium degeneration: from pathogenesis to therapeutic targets in dry age-related macular degeneration	19
The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer’s disease	19
Actin(g) toward a revised understanding of the role of cytoskeletal dynamics in neuronal bioenergetics	19
Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies	18
MET receptor tyrosine kinase promotes the generation of functional synapses in adult cortical circuits	18
Synaptic pathology in multiple sclerosis: a role for Nogo-A signaling in astrocytes?	18
Magnetic resonance imaging focused on the ferritin heavy chain 1 reporter gene detects neuronal differentiation in stem cells	18
Deuterated dextromethorphan/quinidine for agitation in Alzheimer’s disease	18
Optogenetic neuroregeneration	18
Targeting autophagy by polyphenols to prevent glycative stress-toxicity in the brain	18
Accelerating peripheral nerve regeneration using electrical stimulation of selected power spectral densities	18
Activity-dependent remodeling of genome architecture in engram cells facilitates memory formation and recall	18
Extracellular vesicles for neural regeneration after spinal cord injury	18
High-dose biotin neither fosters remyelination nor stimulates malonyl coenzyme A synthesis in the regenerating nerve	18
Strategies to treat neurodegeneration in neuronal ceroid lipofuscinosis: a view onto the retina	18
Low-density lipoprotein receptor-related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson’s disease	18
Transplantation of human neural stem cells repairs neural circuits and restores neurological function in the stroke-injured brain	18
(D-Ser2) oxyntomodulin recovers hippocampal synaptic structure and theta rhythm in Alzheimer’s disease transgenic mice	18
A novel viewpoint in glaucoma therapeutics: enriched environment	18
Stable isotope labeling-mass spectrometry as a new approach to determine remyelination	18
Gut microbiota neurotransmitters: influence on risk and outcome of ischemic stroke	18
The new wave of p75 neurotrophin receptor targeted therapies	18
Neuroinflammation revisited through the microglial lens	18
Alpha-synuclein-induced upregulation of SKI family transcriptional corepressor 1: A new player in aging and Parkinson’s disease?	17
Retraction: Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection	17
Gut microbiota dysbiosis contributes to α-synuclein-related pathology associated with C/EBPβ/AEP signaling activation in a mouse model of Parkinson's disease	17
Blockade of Rho-associated kinase prevents inhibition of axon regeneration of peripheral nerves induced by anti-ganglioside antibodies	17
Neuroprotective effects of Alda-1 mitigate spinal cord injury in mice: involvement of Alda-1-induced ALDH2 activation-mediated suppression of reactive aldehyde mechanisms	17
A novel approach in preventing vascular leakage and angiogenesis in wet age-related macular degeneration	17
Molecular mechanisms after optic nerve injury: Neurorepair strategies from a transcriptomic perspective	17
Circulating extracellular vesicles: friends and foes in neurodegeneration	17
Persistent alterations in gray matter in COVID-19 patients experiencing sleep disturbances: a 3-month longitudinal study	17
Multifaceted superoxide dismutase 1 expression in amyotrophic lateral sclerosis patients: a rare occurrence?	17
How physical and motor training affect cognitive performance: lessons from an inflammatory molecule	17
Neuron-neuron attraction shapes morphology and activity of tissue engineered brain constructs	17
Striatum-specific mechanisms regulate neuronal cell cycle re-entry: the choice between life and death	17
Electroacupuncture treatment improves motor function and neurological outcomes after cerebral ischemia/reperfusion injury	17
Ischemic accumulation of succinate induces Cdc42 succinylation and inhibits neural stem cell proliferation after cerebral ischemia/reperfusion	17
PANoptosis: new insights in regulated cell death in ischemia/reperfusion models	17
Intranasal nerve growth factor for prevention and recovery of the outcomes of traumatic brain injury	17
Can foods influence the onset and progress of neurodegenerative diseases?	17
Rebuilding insight into the pathophysiology of Alzheimer's disease through new blood-brain barrier models	17
Remaking a connection: molecular players involved in post-injury synapse formation	17
Mitochondrial therapeutics and mitochondrial transfer for neurodegenerative diseases and aging	17
Estrogen rapid effects: a window of opportunity for the aging brain?	17
C–C motif chemokine ligand 2/C–C motif chemokine receptor 2 pathway as a therapeutic target and regulatory mechanism for spinal cord injury	17
Iron-handling solute carrier SLC22A17 as a blood–brain barrier target after stroke	17
Taurine: a promising nutraceutic in the prevention of retinal degeneration	17